Project Name：Colesevelam 

Registration Classification：3.1

Formulations and specifications ：Tablets: 625mg; Suspension: 1.875g, 3.75g 

Indications：Lowering cholesterol, lowering blood sugar

Original Research Company：U.S. Genzyme 

Progress ：Pharmaceutical Research in progress